{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-017518","form_type":"8-K","ticker":"BKYI","cik":"0001019034","company_name":"BIO KEY INTERNATIONAL INC","filed_at":"2026-05-18T12:30:16+00:00","discovered_at":"2026-05-18T12:35:00.473488+00:00","generated_at":"2026-05-18T12:37:34.436404+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"BIO-key Q1 revenue up 34% to $2.15M, net loss narrows to $(165K); sees Q2 profitability on 65% revenue jump","bullets":["Q1 2026 revenue $2.15M (+34% YoY); net loss improved to $(165K) from $(737K) in Q1 2025.","Gross margin 82%; cash $2.24M at quarter end; EPS $(0.15) post-reverse split.","Q2 2026 revenue guided ~$2.8M (+65% YoY); expects H1 2026 profitability vs H1 2025 net loss of $(1.9M).","Secured $1.04M license renewal with foreign bank; defense sales surpassed $2M in trailing twelve months.","Shares suspended from Nasdaq, now trading OTC under BKYI; company working to return to Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-017518","json":"https://secwatch.observer/filing/0001437749-26-017518.json","markdown":"https://secwatch.observer/filing/0001437749-26-017518.md","text":"https://secwatch.observer/filing/0001437749-26-017518.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1019034/000143774926017518/0001437749-26-017518-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1019034/000143774926017518/bkyi20260517_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T12:37:34.436404+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a8e6118bed7faeb7e971c274b9c7e1fb6ee349f4","claim":"BIO KEY INTERNATIONAL INC reported first quarter 2026 results: revenue $2.15M, net income $(165K). Guidance raised.","evidence_excerpt":"Q1’26 revenues increased 34% to $2.15M vs. Q1’25 and 74% vs. Q4’25 ● Q1’26 net loss improved to $(165K) vs. $(737K) in Q1’25 and $(1.722M) in Q4’25","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1019034/000143774926017518/0001437749-26-017518-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter 2026"},{"label":"Revenue","value":"$2.15M"},{"label":"Net income","value":"$(165K)"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}